BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30224488)

  • 21. Structural studies of postentry restriction factors reveal antiparallel dimers that enable avid binding to the HIV-1 capsid lattice.
    Goldstone DC; Walker PA; Calder LJ; Coombs PJ; Kirkpatrick J; Ball NJ; Hilditch L; Yap MW; Rosenthal PB; Stoye JP; Taylor IA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(26):9609-14. PubMed ID: 24979782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracellular localisation of Fv1.
    Yap MW; Stoye JP
    Virology; 2003 Mar; 307(1):76-89. PubMed ID: 12667816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A paradigm for virus-host coevolution: sequential counter-adaptations between endogenous and exogenous retroviruses.
    Arnaud F; Caporale M; Varela M; Biek R; Chessa B; Alberti A; Golder M; Mura M; Zhang YP; Yu L; Pereira F; Demartini JC; Leymaster K; Spencer TE; Palmarini M
    PLoS Pathog; 2007 Nov; 3(11):e170. PubMed ID: 17997604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene.
    BĂ©nit L; De Parseval N; Casella JF; Callebaut I; Cordonnier A; Heidmann T
    J Virol; 1997 Jul; 71(7):5652-7. PubMed ID: 9188643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The design of artificial retroviral restriction factors.
    Yap MW; Mortuza GB; Taylor IA; Stoye JP
    Virology; 2007 Sep; 365(2):302-14. PubMed ID: 17493656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the regions of Fv1 necessary for murine leukemia virus restriction.
    Bishop KN; Bock M; Towers G; Stoye JP
    J Virol; 2001 Jun; 75(11):5182-8. PubMed ID: 11333899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retroviral capsid determinants of Fv1 NB and NR tropism.
    Stevens A; Bock M; Ellis S; LeTissier P; Bishop KN; Yap MW; Taylor W; Stoye JP
    J Virol; 2004 Sep; 78(18):9592-8. PubMed ID: 15331691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Megabat-Favored, CA-Dependent Susceptibility to Retrovirus Infection.
    Ohkura S; Horie M; Shimizu M; Nakagawa S; Osanai H; Miyagawa Y; Morita R
    J Virol; 2023 Mar; 97(3):e0180322. PubMed ID: 36779757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ordered assembly of murine leukemia virus capsid protein on lipid nanotubes directs specific binding by the restriction factor, Fv1.
    Hilditch L; Matadeen R; Goldstone DC; Rosenthal PB; Taylor IA; Stoye JP
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5771-6. PubMed ID: 21436027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.
    Kozak CA; Chakraborti A
    Virology; 1996 Nov; 225(2):300-5. PubMed ID: 8918916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pan-vertebrate comparative genomics unmasks retrovirus macroevolution.
    Hayward A; Cornwallis CK; Jern P
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):464-9. PubMed ID: 25535393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRIM5 Retroviral Restriction Activity Correlates with the Ability To Induce Innate Immune Signaling.
    Lascano J; Uchil PD; Mothes W; Luban J
    J Virol; 2016 Jan; 90(1):308-16. PubMed ID: 26468522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteins.
    Perez-Caballero D; Soll SJ; Bieniasz PD
    PLoS Pathog; 2008 Oct; 4(10):e1000181. PubMed ID: 18927623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic map of the region surrounding the retrovirus restriction locus, Fv1, on mouse chromosome 4.
    Stoye JP; Kaushik N; Jeremiah S; Best S
    Mamm Genome; 1995 Jan; 6(1):31-6. PubMed ID: 7719023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous Retroviruses in the Genomics Era.
    Johnson WE
    Annu Rev Virol; 2015 Nov; 2(1):135-59. PubMed ID: 26958910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Convergent Co-option of the Retroviral
    Wang J; Gong Z; Han GZ
    J Virol; 2019 Jul; 93(14):. PubMed ID: 31068420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular diversity and phenotypic pleiotropy of ancient genomic regulatory loci derived from human endogenous retrovirus type H (HERVH) promoter LTR7 and HERVK promoter LTR5_Hs and their contemporary impacts on pathophysiology of Modern Humans.
    Glinsky GV
    Mol Genet Genomics; 2022 Nov; 297(6):1711-1740. PubMed ID: 36121513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral restriction factors in mice.
    Nair S; Rein A
    Virus Res; 2014 Nov; 193():130-4. PubMed ID: 25018022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution of endogenous gammaretroviruses and variants of the Fv1 restriction gene in individual mouse strains and strain subgroups.
    Skorski M; Bamunusinghe D; Liu Q; Shaffer E; Kozak CA
    PLoS One; 2019; 14(7):e0219576. PubMed ID: 31291374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Capsid-binding retrovirus restriction factors: discovery, restriction specificity and implications for the development of novel therapeutics.
    Sanz-Ramos M; Stoye JP
    J Gen Virol; 2013 Dec; 94(Pt 12):2587-2598. PubMed ID: 24026671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.